Goulart, H., Rausch, C., Jabbour, E., Maiti, A., McCall, D., Daver, N., Short, N., Pemmaraju, N., Yilmaz, M., Hammond, D., Kornblau, S., Issa, G., Cuglievan, B., Ravandi, F., Kantarjian, H. (2025). Multiarm Phase I study of the cyclin dependent kinase (CDK4/6) inhibitor palbociclib in combination for patients with relapsed and refractory acute leukemias. Blood. https://doi.org/10.1182/blood-2025-5204